Y
Yi Liu
Researcher at China Pharmaceutical University
Publications - 40
Citations - 1685
Yi Liu is an academic researcher from China Pharmaceutical University. The author has contributed to research in topics: Chemistry & Medicine. The author has an hindex of 11, co-authored 26 publications receiving 1100 citations. Previous affiliations of Yi Liu include Jilin University & National Institutes of Health.
Papers
More filters
Journal ArticleDOI
Glucose-Responsive Sequential Generation of Hydrogen Peroxide and Nitric Oxide for Synergistic Cancer Starving-Like/Gas Therapy.
Wenpei Fan,Wenpei Fan,Nan Lu,Peng Huang,Yi Liu,Zhen Yang,Sheng Wang,Guocan Yu,Yijing Liu,Junkai Hu,Qianjun He,Junle Qu,Tianfu Wang,Xiaoyuan Chen +13 more
TL;DR: A novel treatment paradigm of starving-like therapy is developed for significant tumor-killing effects, more effective than conventional starving therapy by only cutting off the energy supply by using hollow mesoporous organosilica nanoparticle as a biocompatible/biodegradable nanocarrier.
Journal ArticleDOI
Albumin/vaccine nanocomplexes that assemble in vivo for combination cancer immunotherapy.
Guizhi Zhu,Geoffrey M. Lynn,Orit Jacobson,Kai Chen,Yi Liu,Yi Liu,Huimin Zhang,Ying Ma,Fuwu Zhang,Rui Tian,Qianqian Ni,Siyuan Cheng,Zhantong Wang,Zhantong Wang,Nan Lu,Bryant C. Yung,Zhe Wang,Lixin Lang,Xiao Fu,Albert J. Jin,Ido D. Weiss,Harshad D. Vishwasrao,Gang Niu,Hari Shroff,Dennis M. Klinman,Robert A. Seder,Xiaoyuan Chen +26 more
TL;DR: The authors repurpose albumin-binding Evans blue to develop nanovaccines that co-deliver adjuvants and tumor neoantigens to antigen-presenting cells in lymph nodes, resulting in potent and durable antitumour immunity in combination immunotherapy.
Journal ArticleDOI
NIR‐Responsive On‐Demand Release of CO from Metal Carbonyl‐Caged Graphene Oxide Nanomedicine
Qianjun He,Qianjun He,Qianjun He,Dale O. Kiesewetter,Ying Qu,Xiao Fu,Jing Fan,Peng Huang,Yijing Liu,Guizhi Zhu,Yi Liu,Zhiyong Qian,Xiaoyuan Chen +12 more
TL;DR: On-demand release of carbon monoxide (CO) is realized through a novel near-infrared-responsive nanomedicine in favor of the enhancement of therapy efficacy and biosafety of CO therapy.
Journal ArticleDOI
Transformative Nanomedicine of an Amphiphilic Camptothecin Prodrug for Long Circulation and High Tumor Uptake in Cancer Therapy.
Fuwu Zhang,Guizhi Zhu,Orit Jacobson,Yi Liu,Yi Liu,Kai Chen,Guocan Yu,Qianqian Ni,Jing Fan,Zhen Yang,Frederick Xu,Xiao Fu,Zhe Wang,Ying Ma,Gang Niu,Xiaobin Zhao,Xiaoyuan Chen +16 more
TL;DR: A camptothecin prodrug that was well formulated in solution and rapidly transformed into long-circulating nanocomplexes in vivo for highly efficient drug delivery and effective cancer therapy is reported.
Journal ArticleDOI
A novel self-assembled sandwich nanomedicine for NIR-responsive release of NO
Jing Fan,Jing Fan,Nongyue He,Qianjun He,Yi Liu,Ying Ma,Xiao Fu,Yijing Liu,Peng Huang,Xiaoyuan Chen +9 more
TL;DR: The intracellular NIR-responsive release of NO from the GO-BNN6 nanomedicine causes a remarkable anti-cancer effect and is easily triggered and effectively controlled by adjusting the switching, irradiation time and power density of NIR laser.